Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-007103
Filing Date
2025-02-18
Accepted
2025-02-18 09:00:22
Documents
8
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 555691
2 formpre14a_001.jpg GRAPHIC 28967
3 formpre14a_002.jpg GRAPHIC 550663
4 formpre14a_003.jpg GRAPHIC 361446
5 proxy_001.jpg GRAPHIC 401822
6 proxy_002.jpg GRAPHIC 317154
7 proxy_003.jpg GRAPHIC 401822
8 proxy_004.jpg GRAPHIC 235802
  Complete submission text file 0001493152-25-007103.txt   3721137
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41615 | Film No.: 25632934
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)